Tradeoffs

Presenting Color Code: Dismantling Medical Racism Starts in the Classroom

From STAT’s “Color Code” podcast, a look at the groundswell of antiracism work in medicine and medical education, and the backlash these efforts have faced.

Read More

MRIs, Mammograms and the Risk of Breast Cancer Screening Cascades of Care

Stacie Dusetzina shares new research on how much extra care comes after different kinds of breast cancer screenings.

Read More

How One Doctor Is Prepping for a World Without Roe

We talk with a Michigan OB-GYN determined to make sure her hospital is ready if abortion becomes illegal in her state.

Read More

3 Studies That Show the Promise of Telemedicine Data

Ateev Mehrotra explains why a trio of studies on overprescribing antiobiotics has him excited about telemedicine data.

Read More

Too Healthy for the Hospital, Too Sick for the Streets

Medical respite — a decades-old way of caring for homeless people — is on the rise.

Read More

‘Too Healthy for the Hospital, Too Sick for the Streets’ Transcript

‘Too Healthy for the Hospital, Too Sick for the Streets’ Transcript April 28, 2022 Note: This transcript has been created with a combination of machine ears and human eyes. There may be small differences between this document and the audio version, which is one of many reasons we encourage you to listen to the episode! Listen in…

Read More

High-Price Drugs Out of Reach for Many on Medicare

Bianca Frogner breaks down new research on the impact subsidies can have for people on Medicare trying to access lifesaving drugs.

Read More

The Sky-High Price of Insulin and What Lawmakers Are Trying To Do About It

We explore the high cost of insulin in the U.S. and Congress’ latest push to address those prices with Kaiser Health News reporter Bram Sable-Smith.

Read More

The Complex Relationship Between Quality Ratings and Pandemic Deaths in Nursing Homes

Yaa Akosa Antwi shares research on nursing home deaths during COVID suggesting even well-intentioned policies can have unintended consequences.

Read More

How One Alzheimer’s Drug Is Changing the U.S. Drug Approval Conversation

Taking stock of the impact of the Aduhelm saga and Medicare’s decision to restrict coverage of the controversial treatment.

Read More